Nurix Therapeuticsinc Stock Technical Analysis
| NRIX Stock | USD 15.17 0.94 5.83% |
As of the 26th of May, Nurix TherapeuticsInc secures the Downside Deviation of 4.38, risk adjusted performance of 0.0781, and Mean Deviation of 4.35. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nurix TherapeuticsInc, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Nurix TherapeuticsInc, which can be compared to its peers in the industry. Please verify Nurix TherapeuticsInc information ratio and downside variance to decide if Nurix TherapeuticsInc is priced some-what accurately, providing market reflects its recent price of 15.17 per share. Given that Nurix TherapeuticsInc has jensen alpha of 0.5681, we recommend you to check Nurix TherapeuticsInc's last-minute market performance to make sure the company can sustain itself at a future point.
Nurix TherapeuticsInc Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nurix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NurixNurix |
Nurix TherapeuticsInc Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 26.75 | Strong Buy | 12 | Odds |
Most Nurix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nurix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nurix TherapeuticsInc, talking to its executives and customers, or listening to Nurix conference calls.
Nurix TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Nurix TherapeuticsInc Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Nurix TherapeuticsInc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Nurix TherapeuticsInc Trend Analysis
Use this graph to draw trend lines for Nurix TherapeuticsInc. You can use it to identify possible trend reversals for Nurix TherapeuticsInc as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Nurix TherapeuticsInc price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Nurix TherapeuticsInc Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Nurix TherapeuticsInc applied against its price change over selected period. The best fit line has a slop of 0.02 , which means Nurix TherapeuticsInc will continue generating value for investors. It has 122 observation points and a regression sum of squares at 9.05, which is the sum of squared deviations for the predicted Nurix TherapeuticsInc price change compared to its average price change.About Nurix TherapeuticsInc Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nurix TherapeuticsInc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nurix TherapeuticsInc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Nurix TherapeuticsInc price pattern first instead of the macroeconomic environment surrounding Nurix TherapeuticsInc. By analyzing Nurix TherapeuticsInc's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nurix TherapeuticsInc's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nurix TherapeuticsInc specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 (projected) | Current Ratio | 4.51 | 3.4 | 3.06 | Net Debt To EBITDA | 0.29 | 0.17 | 0.2 |
Nurix TherapeuticsInc May 26, 2024 Technical Indicators
Most technical analysis of Nurix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nurix from various momentum indicators to cycle indicators. When you analyze Nurix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0781 | |||
| Market Risk Adjusted Performance | 0.1926 | |||
| Mean Deviation | 4.35 | |||
| Semi Deviation | 3.94 | |||
| Downside Deviation | 4.38 | |||
| Coefficient Of Variation | 844.44 | |||
| Standard Deviation | 6.14 | |||
| Variance | 37.74 | |||
| Information Ratio | 0.1106 | |||
| Jensen Alpha | 0.5681 | |||
| Total Risk Alpha | 0.3168 | |||
| Sortino Ratio | 0.1549 | |||
| Treynor Ratio | 0.1826 | |||
| Maximum Drawdown | 36.91 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 9.8 | |||
| Downside Variance | 19.23 | |||
| Semi Variance | 15.54 | |||
| Expected Short fall | (5.65) | |||
| Skewness | 1.47 | |||
| Kurtosis | 4.27 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Nurix Stock analysis
When running Nurix TherapeuticsInc's price analysis, check to measure Nurix TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix TherapeuticsInc is operating at the current time. Most of Nurix TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Nurix TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix TherapeuticsInc's price. Additionally, you may evaluate how the addition of Nurix TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Nurix TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix TherapeuticsInc. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Revenue Per Share 1.483 | Quarterly Revenue Growth 0.307 | Return On Assets (0.29) | Return On Equity (0.65) |
The market value of Nurix TherapeuticsInc is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Nurix TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix TherapeuticsInc's market value can be influenced by many factors that don't directly affect Nurix TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nurix TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.